What Do Analysts Think About Philip Morris International Inc. (PM)

Group 1 - Philip Morris International Inc. (NYSE:PM) is recognized as a long-term low volatility investment option, with recent developments regarding its ZYN nicotine pouch products aimed at obtaining a Modified Risk Tobacco Product designation from the FDA [1] - The FDA designation would enable the company to inform U.S. adult cigarette smokers that switching to ZYN may reduce their risk of smoking-related diseases [1] - Stifel Nicolaus has reiterated a Buy rating for Philip Morris with a price target of $180, while Jefferies downgraded the stock from Buy to Hold, lowering its price target from $220 to $180, citing limited re-rating potential and competitive pressures from British American Tobacco and Japan Tobacco [2] Group 2 - Philip Morris operates as a holding company focused on delivering products for a smoke-free future, with geographical segments including Europe, South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa, East Asia, Australia, and the Americas [3]